Drug information for APOKYN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; SUBCUTANEOUS 20MG/2ML (10MG/ML) Discontinued   APOMORPHINE HYDROCHLORIDE Apomorphine US WORLDMEDS 21264
2010-09-07 Letter

2010-09-07 Label

2009-01-06 Letter

2009-01-06 Letter

2004-08-27 Review

2004-05-04 Label

2004-04-29 Letter
INJECTABLE; SUBCUTANEOUS 30MG/3ML (10MG/ML) Prescription  (Reference Drug) APOMORPHINE HYDROCHLORIDE Apomorphine US WORLDMEDS   "

Drug Adverse Effects information for APOKYN

Role code Indications Reaction # Reports
PS PARKINSON'S DISEASE CARDIAC DISORDER 1
PS PARKINSON'S DISEASE COMPUTERISED TOMOGRAM ABNORMAL 1
PS PARKINSON'S DISEASE CONDITION AGGRAVATED 1
PS PARKINSON'S DISEASE CONTUSION 1
PS PARKINSON'S DISEASE COOMBS TEST POSITIVE 1
PS PARKINSON'S DISEASE FALL 1
PS PARKINSON'S DISEASE HEPATIC INFECTION BACTERIAL 1
PS PARKINSON'S DISEASE LIVER ABSCESS 1
PS PARKINSON'S DISEASE MALAISE 1
Ads by Google